| DC Field | Value | Language |
|---|
| dc.contributor.author | Pokrovsky, V. M. | - |
| dc.date.accessioned | 2026-10-12T14:08:43Z | - |
| dc.date.available | 2026-10-12T14:08:43Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | Pokrovsky, V.M. Evaluation of pharmacological correction of hypoxic-ischemic encephalopathy sequelae using peptide erythropoietin analogs in a mouse model of mild and moderate hypoxic-ischemic encephalopathy during the late remodeling phase / V.M. Pokrovsky // Research Results in Pharmacology. - 2026. - Vol.12, №1.-P. 56-68. - DOI: 10.18413/rrpharmacology.12.1075. - Refer.: p. 67-68. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67111 | - |
| dc.description.abstract | In this experimental study, Epobis and Ara-290 normalized mild HIE hyperlocomotion in the open field, whereas EPO mainly improved anxiety-like behavior and only Epobis increased peripheral time toward intact levels | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | hypoxic-ischemic encephalopathy | ru |
| dc.subject | caffeine neurostimulation test | ru |
| dc.subject | Epobis | ru |
| dc.subject | Ara-290, | ru |
| dc.subject | EPO | ru |
| dc.subject | laser speckle contrast imaging | ru |
| dc.title | Evaluation of pharmacological correction of hypoxic-ischemic encephalopathy sequelae using peptide erythropoietin analogs in a mouse model of mild and moderate hypoxic-ischemic encephalopathy during the late remodeling phase | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 1
|
